Paratek Pharmaceuticals has completed the acquisition of Optinose, valued at almost $330m, broadening its commercial product ...

Paratek Pharmaceuticals, Inc., a privately held pharmaceutical company focused on the development and commercialization of specialty therapies for specialists and community care providers, that ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Department of Pharmacology and Toxicology, University of Utah, 30 S 2000 E, Room 201, Salt Lake City, Utah 84112, and Department of Pediatrics, University of Utah, Williams Building, P.O. Box 581289, ...

2025-05-19 13:42 male enhancement pills zyrexin flonase and erectile dysfunction And erectile dysfunction doctors las vegas male enhancement pills spencers. But the flourishing period is extremely ...

Objective: To compare the cost effectiveness of fluticasone propionate (FP) and triamcinolone acetonide (TA) in patients with persistent asthma. Design: Resource utilisation and clinical data were ...

Background: A study was undertaken to examine the dose-response relation of inhaled fluticasone in adolescents and adults with asthma. Methods: A meta-analysis was carried out of randomised clinical ...

Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with Apotex for exclusive rights in Mexico for the commercialization of clobetasol propionate ophthalmic ...

APP13007 was approved by the U.S. Food and Drug Administration (FDA) in 2024. APP13007's active ingredient is the corticosteroid clobetasol propionate, and it is derived from Formosa Pharma's ...